Lyme disease: Review

Archives of Medical Science

Volumn 8, Issue 6, 2012, Pages 978-982

  Biesiada, Grazyna ^a   Czepiel, Jacek ^a   Leśniak, Maciej R ^a   Garlicki, Aleksander ^a   Mach, Tomasz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Borreliosis; Lyme borreliosis; Tick

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; DOXYCYCLINE; IMMUNOGLOBULIN M ANTIBODY; PENICILLIN G;

ACRODERMATITIS; ANTIBIOTIC THERAPY; ATROPHIC CHRONIC ACRODERMATITIS; BONE PAIN; BORRELIA BURGDORFERI; BORRELIA INFECTION; BORRELIAL LYMPHOCYTOMA CUTIS; COLLAGEN DEGRADATION; CRANIAL NERVE PARALYSIS; ERYTHEMA CHRONICUM MIGRANS; HUMAN; LYME DISEASE; LYMPHOCYTOMA; MEDICAL HISTORY; MEMORY DISORDER; PERIPHERAL NEUROPATHY; RADICULAR PAIN; REVIEW; TICK BITE; TREATMENT DURATION; WHITE MATTER;

EID: 84873146792     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.30948     Document Type: Review

References (29)

1. Cechová L, Durnová E, Sikutová S, Halouzka J, Nemec M. Characterization of spirochetal isolates from arthropods collected in South Moravia, Czech Republic, using fatty acid methyl esters analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2004;808:249-54. (Pubitemid 38952919)
2. Flisiak R, Prokopowicz D. Antibodies against Borrelia garinii in diagnosis of Lyme borreliosis [Polish]. Przegl Lek 2000;57:147-9.
3. Halouzka J, Wilske B, Stünzner D, Sanogo YO, Hubálek Z. Isolation of Borrelia afzelii from overwintering Culex pipiens biotype molestus mosquitoes. Infection 1999;27:275-7. (Pubitemid 29443687)
4. Stanczak J, Racewicz M, Kubica-Biernat B, et al. Prevalence of Borrelia burgdorferi sensu lato in Ixodes ricinus ticks (Acari, Ixodidae) in different Polish woodlands. Ann Agric Environ Med 1999;6:127-32. (Pubitemid 30004528)
5. De Carvalho IL, Fonseca JE, Marques JG, et al. Vasculitis-like syndrome associated with Borrelia lusitaniae infection. Clin Rheumatol 2008;27:1587-91.
6. Derdáková M, Lencáková D. Association of genetic variability within the Borrelia burgdorferi sensu lato with the ecology, epidemiology of Lyme borreliosis in Europe. Ann Agric Environ Med 2005;12:165-72.
7. Murray TS, Shapiro ED. Lyme disease. Clin Lab Med 2010;30:311-28.
8. Asbrink E, Hovmark A. Classification, geographic variations, and epidemiology of Lyme borreliosis. Clin Dermatol 1993;11:353-7. (Pubitemid 23261301)
9. Hubálek Z, Halouzka J. Distribution of Borrelia burgdorferi sensu lato genomic groups in Europe, a review. Eur J Epidemiol 1997;13:951-7. (Pubitemid 28046727)
10. Nau R, Christen HJ, Eiffert H. Lyme disease - current state of knowledge. Dtsch Arztebl Int 2009;106:72-81.
11. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet 2012;379:461-73.
12. Marques A. Chronic Lyme disease: a review. Infect Dis Clin North Am 2008;22:341-60. (Pubitemid 351608543)
13. Müllegger RR, Glatz M. Skin manifestations of lyme borreliosis: diagnosis and management. Am J Clin Dermatol 2008;9:355-68.
14. Bitar I, Lally EV. Musculoskeletal manifestations of Lyme disease. Med Health R I 2008;91:213-5.
15. Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Moniuszko A. Articular symptoms in Lyme borreliosis. Pol Merk Lek 2008;24:542-4.
16. Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007;69:91-102. (Pubitemid 47025211)
17. Halperin JJ. Nervous system lyme disease: diagnosis and treatment. Rev Neurol Dis 2009;6:4-12.
18. Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol 2009;30:1079-87.
19. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Inf Dis 2006;43:1089-134. (Pubitemid 44637131)
20. Wormser GP, Nadelman RB, Dattwyler RJ, et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin Infect Dis 2000;31 Suppl 1:1-14.
21. Bacon RM, Kugeler KJ, Mead PS. Centers of Disease Control and Prevention (CDC) Surveillance for Lyme disease - United States, 1992-2006. MMWR Surveill Summ 2008;57:1-9.
22. Bartunek P, Gorican K, Veiser T, Táborsky M, Hulinská D. Significance of Borrelia infection in development of dilated cardiomyopathy (a pilot study). Prague Med Rep 2007;108:339-47.
23. Flisiak R, Pancewicz S. Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases [Polish]. Przegl Epidemiol 2008;62:193-9.
24. Aberer E. Lyme borreliosis - an update [German]. J Dtsch Dermatol Ges 2007;5:406-14.
25. Kaplan RF, Trevino RP, Johnson GM, et al. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 2003;60:1916-22. (Pubitemid 36736006)
26. Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92. (Pubitemid 32634566)
27. Gasiorowski J, Witecka-Knysz E, Knysz B, Gerber H, Gladysz A. Diagnosis of Lyme disease [Polish]. Med Pr 2007;58:439-47.
28. Hermanowska-Szpakowicz T, Swierzbinska R, Zajkowska J, Iżycka-Herman A. Actual diagnostic possibilities of Lyme borreliosis [Polish]. Pol Merk Lek 2000;7:69-71.
29. Hunfeld KP, Fingerle V, Stanek G, et al. European multicenter study for evaluation of a new enzyme immunoassay for detection of IgG antibodies against Borrelia burgdorferi sensu lato; 10th Int. conference on Lyme borreliosis and other tick-borne diseases; 2005 Sep. 11-15; Vienna, Austria.